Encision Performance
| ECIADelisted Stock | USD 0.44 0.00 0.00% |
The firm shows a Beta (market volatility) of -0.39, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Encision are expected to decrease at a much lower rate. During the bear market, Encision is likely to outperform the market. Encision right now shows a risk of 0.0%. Please confirm Encision jensen alpha, kurtosis, and the relationship between the variance and potential upside , to decide if Encision will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Encision has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Encision is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 385.1 K | |
| Total Cashflows From Investing Activities | -35.4 K |
Encision |
Encision Relative Risk vs. Return Landscape
If you would invest 44.00 in Encision on September 29, 2024 and sell it today you would earn a total of 0.00 from holding Encision or generate 0.0% return on investment over 90 days. Encision is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Encision, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Encision Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Encision's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Encision, and traders can use it to determine the average amount a Encision's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ECIA |
Based on monthly moving average Encision is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Encision by adding Encision to a well-diversified portfolio.
Encision Fundamentals Growth
Encision Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Encision, and Encision fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Encision Pink Sheet performance.
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.0831 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 6.09 M | ||||
| Shares Outstanding | 11.76 M | ||||
| Price To Earning | 16.67 X | ||||
| Price To Book | 1.99 X | ||||
| Price To Sales | 0.75 X | ||||
| Revenue | 7.54 M | ||||
| EBITDA | 760.82 K | ||||
| Cash And Equivalents | 827.94 K | ||||
| Cash Per Share | 0.07 X | ||||
| Total Debt | 206 K | ||||
| Debt To Equity | 0.35 % | ||||
| Book Value Per Share | 0.22 X | ||||
| Cash Flow From Operations | 219.95 K | ||||
| Earnings Per Share | 0.01 X | ||||
| Total Asset | 5.66 M | ||||
| Retained Earnings | (23.79 M) | ||||
| Current Asset | 2.6 M | ||||
| Current Liabilities | 1.18 M | ||||
About Encision Performance
By analyzing Encision's fundamental ratios, stakeholders can gain valuable insights into Encision's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Encision has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Encision has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado. Encision operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 31 people.Things to note about Encision performance evaluation
Checking the ongoing alerts about Encision for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Encision help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Encision is not yet fully synchronised with the market data | |
| Encision has some characteristics of a very speculative penny stock | |
| Encision has a very high chance of going through financial distress in the upcoming years | |
| About 46.0% of the company shares are held by company insiders |
- Analyzing Encision's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Encision's stock is overvalued or undervalued compared to its peers.
- Examining Encision's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Encision's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Encision's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Encision's pink sheet. These opinions can provide insight into Encision's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Encision Pink Sheet
If you are still planning to invest in Encision check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Encision's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |